Cameroon vs Lesotho: HIV/AIDS deaths averted by antiretroviral therapy
Cameroon
29,674 deaths
in 2024
Lesotho
16,464 deaths
in 2024
Cameroon rank
12th
Lesotho rank
15th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Cameroon
- Lesotho
How they compare
Cameroon currently reports 29,674 deaths against 16,464 deaths in Lesotho, a difference of 13,210 deaths.
That makes Cameroon's figure about 1.8 times Lesotho's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Lesotho ahead.
Cameroon ranks 12th and Lesotho ranks 15th of 157 countries.
Cameroon has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Cameroon | Lesotho | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 4,683 deaths | 3,511 deaths | 1,172 deaths | Cameroon |
| 2010s | 17,909 deaths | 15,323 deaths | 2,586 deaths | Cameroon |
| 2020s | 28,409 deaths | 17,301 deaths | 11,108 deaths | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Cameroon or Lesotho?
- Cameroon, at 29,674 deaths against 16,464 deaths in Lesotho as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Cameroon and Lesotho?
- 13,210 deaths, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Lesotho?
- 35 years are reported by both, from 1990 to 2024.
- How do Cameroon and Lesotho rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Cameroon ranks 12th and Lesotho ranks 15th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.